Previous Close | 0.3200 |
Open | 0.3300 |
Bid | 0.3450 x 0 |
Ask | 0.3500 x 0 |
Day's Range | 0.3300 - 0.3650 |
52 Week Range | 0.1300 - 0.4300 |
Volume | |
Avg. Volume | 90,754 |
Market Cap | 24.316M |
Beta (5Y Monthly) | -0.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0370 |
Earnings Date | Jan 25, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.00 |
DIagnos Gets Approval for Quebec Hospitals DIagnos Gets Approval for Quebec Hospitals BROSSARD, Quebec, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce that the Quebec government has given the green light to Diagnos' Artificial Intelligence (AI) technology to screen and as
BROSSARD, Quebec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a non-brokered private placement (“Private Placement”) of 5 units (each a “Unit”) issued at a price of $50,000 per Unit for gross proceeds of $250,000. For the period of November 25, 2022 to this date,
BROSSARD, Quebec, Dec. 15, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that in connection with the closing of the private placement announced on December 12, 2022, the Corporation paid a cash commission of $9,000 to one qualified person (“Finder”) and issued 40,909 finder’s warrants to the Finde